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Introduction  and  objectives: Drug  provocation  tests  (DPTs)  are  the  gold-standard  method  to
diagnose non-immediate  hypersensitivity  reactions  (NIHSR)  to  beta-lactam  antibiotics  (BL)  in
children.  Our  aim  was  to  compare  the  negative  predictive  value  (NPV)  of  one-day  (short)  DPT
versus 3--7  days  (extended)  DPT  for  the  diagnosis  of  NIHSR  to  BL  in  paediatric  age.  A  secondary
aim was  to  compare  confidence  on  drug  re-exposure  after  short  and  extended  negative  DPTs.
Methods: The  occurrence  of  HSR  on  drug  re-exposure  and  drug  refusal  after  negative  diagnostic
DPTs were  evaluated  in  children/adolescents  with  a  history  of  NIHSR  to  BL  using  a  questionnaire
performed  six  months  to  ten  years  after  DPT.  Patients  were  divided  into  two  groups  according
to the  protocol  performed:  short  DPT  vs.  extended  DPT.
Results:  We  enrolled  212  children  and  adolescents  (86  females,  126  males,  mean  age  at  DPT
5.52 years,  p25  =  3  years,  p75  =  7.25  years):  69  tested  with  short  DPT,  and  143  with  extended
DPT. The  NPV  of  both  types  of  DPT  together  was  95.2%.  The  NPV  of  short  DPT  was  97.5%  and  the
NPV of  extended  DPT  was  93.8%  (p  =  0.419).  After  negative  DPT,  beta-lactams  were  refused  by
carers in  14.75%  of  the  children  requiring  subsequent  treatment,  6.98%  in  the  short  DPT  group
and 18.99%  in  the  extended  DPT  group  (p  =  0.074).
Abbreviations: NIHSR, non-immediate hypersensitivity reactions; BL, beta-lactam antibiotics; Amox/clav, amoxicillin and clavulanate;
DPT, drug provocation test; HSR, hypersensitivity reaction; NPV, negative predictive value; CHP, Centro Hospitalar do Porto; HDE, Hospital
D. Estefânia.
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Conclusions:  In  our  paediatric  sample,  prolonging  drug  administration  did  not  increase  the  NPV
of diagnostic  DPT  for  NIHSR  to  BL  or  reduce  drug  refusal.  Altogether,  the  data  here  reported
suggest that,  however  intuitive,  prolonging  DPT  is  not  beneficial  in  the  parameters  analysed.


































































round  10%  of  people  avoid  some  type  of  medication  due
o  fear  of  allergic  reactions.1 Suspicion  of  drug  allergy  has
 great  impact  in  clinical  practice.2 However,  only  a small
ercentage  of  patients  are  confirmed  to  have  drug  HSR  in
ubsequent  work-up.  This  over-diagnosing  is  particularly  fre-
uent  among  children1,3--8 and  allergy  ‘‘mislabelling’’  often
ersists  into  adulthood.
In  children,  beta-lactam  antibiotics  (BL)  are  the  most
ommon  medications  suspected  of  being  involved  in  drug
SR  and  can  mediate  all  ‘Gell  and  Coombs’  types  of  HSR.9
ost  suspected  HSR  to  BL  in  children  are  mild  non-immediate
kin  eruptions  occurring  in  the  context  of  treatment  for
nfection.10,11 Viral  infections  are  the  most  common  cause
f  maculopapular  or  urticarial  eruptions  in  children,  lead-
ng  to  frequent  misdiagnosis  of  HSR  to  concurrent  BL
reatment.4,6,12
It  is  generally  agreed  that  drug  provocation  tests  (DPT)
ith  the  culprit  antibiotic  are  the  ‘‘gold  standard’’  for
he  diagnosis  of  non-immediate  HSR  to  BL.13,14 Clinical  his-
ory  criteria  cannot  accurately  predict  BL  allergy15 whereas
lood  allergy  tests16 and  other  allergy  in  vivotests,  such
s  intradermal  testing  or  patch  testing,  have  low  sensitiv-
ty  in  this  clinical  context7,8,10,12,17,18 and  may  be  difficult
o  implement  in  young  children.  Recent  evidence  suggests
hat,  after  a  careful  clinical  history,  non-immediate  mild
utaneous  eruptions  in  children  should  be  investigated  by
‘up-front’’  DPT  with  the  culprit  drug,12,19--22 and  such  an
pproach  has  been  included  in  some  guidelines.23
The  negative  predictive  value  (NPV)  of  DPTs  for  non-
mmediate  HRS  to  BL  has  been  reported  to  be  as  high  as
0--98%4,8,24 with  some  variation  attributable  to  differences
n  the  populations  tested  and  DPT  protocols.  However,  some
atients  do  have  HSR  after  negative  DPT,  and  no  current
ethod  can  further  identify  which  patients  are  at  risk  of
SR  on  re-exposure.  Some  DPT  modifications  were  proposed
o  improve  accuracy,  including:
.  Extended  DPT  protocols,17,24--27 as  it  has  been  argued
that  one-day  (‘‘short’’)  DPT  protocols  might  provide  an
exposure  that  is  too  small  to  elicit  a  full  non-immediate
HSR.  It  is  also  well  known  that,  after  a  negative  DPT,
some  patients,  carers  or  attending  physicians  remain
reluctant  to  use  or  prescribe  the  previously  suspected
medication.28 Extended  protocols  were  proposed  to  also
increase  patients/physicians’  confidence  in  subsequent
use  of  the  drug.29
.  Retesting  after  a  first  negative  DPT  with  the  culprit  drug.
However,  recent  evidence  suggests  that  retesting  adds
little  diagnostic  benefit.30,31
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rotocols  in  the  context  of  non-immediate  HSR  in  children  is
carce.  The  primary  aim  of  this  study  is  to  compare  the  NPV
f  one-day  (short)  DPT  versus  3--7  days  (extended)  DPT  pro-
ocols  for  the  diagnosis  of  non-immediate  cutaneous  HSR  to
L  in  paediatric  age.  A  secondary  aim  is  to  compare  the  fre-
uency  of  drug  use  (re-exposure)  after  short  and  extended
egative  DPTs.  We  did  not  intend  to  compare  the  perfor-
ance  of  the  two  protocols  in  terms  of  diagnostic  sensitivity.
ethods
e  retrospectively  collected  data  from  212  children  and
dolescents  with  a  negative  diagnostic  DPT  performed
etween  2007  and  2015  as  part  of  the  investigation  of  non-
mmediate  cutaneous  HSR  to  BL  in  two  Hospitals  in  Portugal
Centro  Hospitalar  do  Porto,  CHP,  in  Porto,  and  Hospital  Dona
stefânia,  HDE,  in  Lisbon),  and  completed  telephone  ques-
ionnaires  to  the  carers  of  the  patients  between  2015  and
017.
rug  provocation  tests
ll  patients  tested  had  previous  cutaneous,  non-severe,  non-
mmediate  HSR  to  BL  (defined  as  reactions  that  occurred
ore  than  1  hour  after  the  previous  dose  intake  and  with
haracteristic  manifestations  of  non-immediate  hypersen-
itivity).  After  informed  consent  by  the  parents/carers,  the
atients  were  tested  ‘‘up-front’’  (i.e.,  without  previous  skin
esting)  using  one  of  two  DPT  protocols  with  the  culprit  drug
diagnostic  DPT):
.  ‘‘short’’  DPT  --  one-day  administration  of  an  age-  and
weight-adjusted  dose  of  the  suspected  drug  according
to  ENDA  guidelines  (total  dose  was  calculated  taking
into  consideration  the  daily  doses  and  administration
intervals  recommended  to  treat  the  infection  present
when  the  suspected  HSR  occurred).  The  whole  DPT  pro-
tocol  was  usually  performed  in  day-hospital  and  the  total
dose  was  divided  in  2--4  administrations  with  intervals  of
30--60  min,  followed  by  a  vigilance  period  of  at  least  3  h
before  medical  discharge.  No  further  doses  were  admin-
istered  at  home;
.  ‘‘extended’’  DPT  --  the  first  day  was  identical  to  the
‘‘short’’  DPT  protocol  but  antibiotic  administration  con-
tinued  at  home  on  the  following  days  using  standard
doses  ‘‘as  per  treatment’’  until  the  number  of  doses  that
reportedly  triggered  the  reaction  was  achieved.
icalKey.com by Elsevier on January 07, 2020.
























Duration  of  beta-lactams  DPT  in  children  
The  assignment  to  short  or  extended  DPT  in  CHP  was
chronological:  from  2007  to  2012  all  children  were  tested
with  short  DPTs  and  after  2012  all  were  tested  with  extended
DPT.  In  HDE,  the  assignment  to  short  or  extended  DPT  was
random.
All  patients  included  in  this  study  had  negative  DPTs.
DPTs  were  considered  negative  when  no  symptoms  devel-
oped  during  DPT  or  in  the  seven  days  after  the  last  drug
administration.  After  a  negative  DPT,  patients’  parents  and
carers  were  explained  the  result  and  limitations  of  the  DPT
and  were  instructed  that  BL  could  be  safely  used  in  subse-
quent  bacterial  infections.  A  written  report  was  provided  to
the  patient  and  the  assistant  physician.  Drug  HS  ‘‘labelling’’
and  the  Hospital’s  informatics  limitations  to  beta-lactam
prescription  were  removed.
Re-exposure  questionnaire
Six  months  to  ten  years  after  negative  DPT,  the  carers  of
patients  were  contacted  by  telephone  to  obtain  informa-
tion  regarding  subsequent  use  of  beta-lactams.  A  standard
questionnaire  with  the  following  questions  was  completed:
1.  After  the  negative  DPT,  was  the  patient  administered  the
tested  beta-lactam  antibiotic  ever  again?
2.  If  the  answer  to  question  1  was  positive,  did  the  child
have  manifestations  of  HSR?  If  so,  what  were  the  mani-
festations?3.  If  the  answer  to  question  1  was  negative  (patient  was
never  treated  with  BL  again),  what  was  the  reason?  Were
BL  not  needed?  Were  the  patient/carer/attending  physi-




Table  1  Short  vs.  extended  DPT  sample  characteristics.
Total  
Number  of  patients  212  69
Female sex  86  (40.1%)  29
Age at  DPT,  years
Mean  5.52  5.
Median (p25--p75)  4  (3--7.25)  4  
HSR symptoms
Mucocutaneous  199a 92.0%  66
Mucocutaneous  +  digestive  8  3.75%  2  
Serum sickness-like  disease  3  1.4%  0  
Others, ill-defined  2  0.95%  1  
DPT antibiotic
Amoxicillin  102  48.1%  37
Amox/clav 92  43.4%  26
Cefuroxime  11  5.2%  4  
Cefaclor  5  2.4%  1  
Cefatrizine  2  0.9%  1  
a Mucocutaneous includes maculopapular exanthema with mucous an
(191), skin erythemas (4) and urticariphorm exanthema (1).
DPT: drug provocation test; HSR: hypersensitivity reaction; MPE: mac
NS: non-significant.
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tatistical  analysis
PV  were  calculated  and  compared  using  chi-square  test
sing  STATA  (StataCorp.  2017.  Stata  Statistical  Software:
elease  15.  College  Station,  TX,  USA:  StataCorp  LLC).  The
istribution  of  other  variables  between  the  two  groups  were
ompared  using  Student’s  t-test,  Fisher-exact-test  and  chi-
quare  test  where  appropriate.  The  level  of  significance
onsidered  was  ˛  =  0.05.
thics  and  consent
his  study  was  approved  by  an  institutional  ethics  commit-
ee  and  the  database  was  registered  in  the  Portuguese  Data
rotection  Authority.  Children’s  parents  or  the  entitled  care-
ivers  signed  an  informed  consent  for  the  study.
esults
 total  of  212  patients  were  included:  151  in  CHP  and  61
n  HDE,  86  females,  126  males,  average  age  at  DPT  5.52
ears  (median  four  years,  p25--p75:  3--7.25  years).  Sixty-
ine  (32.5%)  patients  were  tested  with  short  DPT  and  143
67.5%)  with  extended  DPT.  No  significant  differences  in
ge,  sex,  type  of  reaction  or  DPT  antibiotic  were  observed
etween  the  groups  (Table  1).
hort  and  extended  DPTs  have  similar  negative
redictive  valuene  hundred  and  four  of  the  212  patients  (49.1%)  were  re-
xposed  to  beta-lactams  months  to  years  after  the  negative
PT  (Fig.  1):  40/69  (58%)  in  the  short  DPT  group  and  64/143
Short  DPT  Extended  DPT  p-value
 (32.5%)  143  (67.5%)  --
 (42.0%)  57  (39.9%)  NSp  =  0.76
53 NS
p  =  0.48(3--8)
 94.2%  133  90.9% NS
p  =  0.552.9%  6  4.2%
0%  3  2.1%
1.45%  1  0.7%
 53.6%  65  48.6% NS
p  =  0.23
 37.7%  66  43.1%
5.8%  7  4.2%
1.45%  4  3.5%
1.45%  1  0.7%
gioedema (n = 3), maculopapular exanthema without angioedema
ulopapular exanthema; Amox/clav: amoxicillin and clavulanate;
linicalKey.com by Elsevier on January 07, 2020.
020. Elsevier Inc. All rights reserved.




















































































igure  1  Patient  distribution  in  the  two  study  groups  and  qu
ypersensitivity.
44.8%)  in  the  extended  DPT  group  (p  =  0.071).  Many  factors
ay  have  contributed  to  the  frequency  of  subsequent  antibi-
tic  use,  e.g.,  time  interval  between  DPT  and  telephone
nterview,  rate  of  infections,  age  of  the  patient,  among  oth-
rs.  Carer/assistant  physician  refusal  of  subsequent  use  will
e  analysed  below.  Among  the  patients  re-exposed  to  BL
fter  negative  DPT,  5/104  patients  reported  a  suspected  HSR
n  re-exposure  (NPV  was  95.2%,  when  both  DPT  protocols
ere  analysed  together).
On  re-exposure,  only  1/40  patients  in  the  short  DPT
roup  developed  a  suspected  HSR  (NPV:  97.5%)  compared
o  4/64  patients  in  the  extended  DPT  group  (NPV:  93.75%),
 =  0.419  (Table  2).  All  five  patients  who  developed  HSR  on
e-exposure  had  maculopapular  exanthema  (MPE)  on  the
SR  index  and  again  presented  MPE  on  re-exposure.  All  five
ere  male,  average  age  at  DPT  was  five  years  and  the  BL
nvolved  were  amoxicillin/clavulanate  in  three  patients  and
moxicillin  in  two.
ate  of  drug  refusal  after  negative  DPT  was  smaller
n the  short  DPT  protocol
e  then  focused  on  those  patients  who,  after  negative  DPT,
equired  BL  for  subsequent  infections  but  refused  the  treat-
ent  due  to  fear  of  HSR.  The  decision  to  refuse  treatment
ight  have  been  taken  by  the  patient,  carers  or  prescribing
hysicians.
Despite  previous  negative  DPT,  antibiotic  treatment  was
efused  in  18  out  of  122  patients  that  required  BL  (14.75%).





Downloaded for Anonymous User (n/a) at Hospital Centre of Central Lisbon from Clin
For personal use only. No other uses without permission. Copyright ©2020nnaire  results.  DPT:  drug  provocation  test;  AB:  antibiotic;  HS:
ge  vs.  4.47  years,  p  =  0.021).  No  significant  differences
ere  observed  between  patients  who  refused  the  drug  and
hose  re-exposed  in  terms  of  type  of  initial  HSR  (mucocuta-
eous  reaction  in  16/18  vs.  98/104,  respectively,  p  =  0.335).
he  most  frequent  culprit  drug  in  patients  who  refused  re-
xposure  was  amoxicillin/clavulanate  (11  patients,  61.1%)
nd  amoxicillin  in  the  remaining  seven  patients  (38.9%).  In
atients  who  were  re-exposed  (104  patients),  the  suspected
L  were  amoxicillin/clavulanate  in  40  patients  (38.5%),
moxicillin  in  57  (54.8%),  cefuroxime  in  five  (4.8%)  and
efaclor  in  two  (1.9%).  Amoxicillin/clavulanate  was  more
requent  in  those  refusing  retreatment  (p  =  0.072).
In  the  short  DPT  group,  refusal  occurred  in  three  out  of
3  (6.98%)  of  the  patients  that  were  subsequently  prescribed
L  antibiotics,  whereas  in  the  extended  DPT  group,  refusal
ccurred  in  15  out  of  79  patients  (18.99%),  p  =  0.074.
iscussion
n  this  study  we  aimed  to  determine  whether  prolonging  the
xposition  to  the  antibiotic  improved  the  negative  predic-
ive  value  of  DPTs  for  the  diagnosis  of  mild  non-immediate
SR  to  beta-lactams  in  children.  This  is  a  relevant  ques-
ion  because  several  alterations  to  the  DPT  protocols  have
een  suggested  and  implemented  but  few  data  have  been
ublished  directly  comparing  the  two  methods  to  confirm
dditional  benefits.  We  evaluated  both  the  recurrence  of
SR  symptoms  on  re-exposure,  and  drug  refusal  after  nega-
ive  one-day  DPTs  versus  longer  DPTs.
icalKey.com by Elsevier on January 07, 2020.
. Elsevier Inc. All rights reserved.
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Table  2  Negative  predictive  value  of  the  DPT  and  antibiotic  refusal  after  negative  DPT.
Total  Short  Protocol  Extended  Protocol  p-value










p  =  0.419
Antibiotic refusal








p  =  0.074
HSR: hypersensitivity reaction; DPT: drug provocation test; NS: non-significant.
Table  3  Summary  of  current  study  and  previously  reported  findings.
Age  group  Number  of
patients
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Ponvert  et  al.4 Children  141  Beta-lactams  Immediate  and
non-immediate
5--7  days  66%  97.9%  --
Misirlioglu
et al.24





1--6  days  51%b 93.3%a 31%b
Demoly  et  al.34 Adults  457  Beta  lactams  Immediate  and
non-immediate
1  day  25.8%  94.1%  --





1  day  17%a 100%a 25.3%c





















Data concerning all types of antibiotics.
c For all drugs tested (beta lactams and non-beta lactams).
Our  results  confirm  the  high  NPV  of  diagnostic  DPTs  in
non-immediate  HSR  to  beta-lactams  in  children  (95.2%,  both
DPT  protocols  together).  Similar  values  were  reported  in
other  studies  (Table  3)  despite  differences  in  methodologies,
type  of  HSR  and  populations  enrolled.  When  comparing  the
NPV  of  short  versus  extended  DPTs,  we  found  no  differences
between  protocols,  although  there  were  more  suspected
false  negatives  in  the  extended  group  (NPV  short  DPT  97.6%
vs.  NPV  extended  DPT  93.8%).  Such  a  small  difference  is
likely  clinically  irrelevant.
Refusal  of  the  suspected  drug  after  negative  DPT  remains
a  significant  issue.  In  our  study,  a  total  of  14.75%  of  patients
were  refused  BL  after  a  negative  DPT.  In  our  sample,
extended  protocols  did  not  increase  confidence  in  subse-
quent  use  and,  in  fact,  drug  refusal  was  higher  in  the
extended  DPT  group.  The  reasons  for  this  are  unclear  and
were  not  explored  in  our  study.  We  may  speculate  that  psy-
chological  factors,  such  as  a  ‘‘backfire  effect’’,32 may  have
played  a  role.  We  noted  that  refusal  was  more  frequent  in
children  tested  with  amoxicillin/clavulanate  and  we  spec-
ulate  that  perhaps  some  non-allergic  side  effects  of  longer
treatments  with  amoxicillin/clavulanate,  such  as  digestive
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dministration  to  test  non-immediate  HSR  to  beta-lactams
n  children  in  the  parameters  analysed.  Previously  pub-
ished  literature  argued  for  the  safety  of  extended  DPTs  and
eported  that  some  patients  developed  HSR  symptoms  only
fter  several  days  of  drug  administration  during  extended
PTs  (in  adults).25--27 It  is  however  unclear  whether  these
atients  would  have  developed  these  delayed  symptoms  if
 short  DPT  had  been  performed.  Data  directly  comparing
ensitivity,  NPV  and  re-exposure  confidence  of  short  versus
xtended  DPTs  protocols  is  generally  lacking  and  our  study
ddresses  the  latter  two  questions.
Our  study  included  a  large  number  of  children  with  simi-
ar  characteristics  in  both  groups  (e.g.,  age,  type  of  HSR  or
uspected  antibiotic).  Both  DPT  protocols  were  performed
n  the  two  hospitals  to  mitigate  differences  in  procedures,
ersonal  recommendations  or  regional  differences.  In  our
tudy,  a  large  number  of  patients  (104/212,  49.1%)  were
e-exposed  to  the  culprit  drug  subsequent  to  negative  DPT.
 wide  variation  on  re-exposure  rates  has  been  reported
Table  3) and  the  reasons  for  avoidance  have  been  explored
lsewhere.33 The  high  percentage  of  re-exposure  in  our
tudy  may,  at  least  in  part,  be  explained  by  the  long  period
etween  the  DPT  and  the  questionnaire  in  some  patients,
linicalKey.com by Elsevier on January 07, 2020.






























































nd  the  young  age  of  the  patients  (e.g.,  children  have  more
requent  infections  providing  more  possibilities  of  antibiotic
rescription,  parents  are  possibly  more  abiding  to  physi-
ians’  prescriptions  than  adult  individuals  deciding  on  their
wn  health).
We  are  aware  of  some  limitations  in  our  study.  We  used
 questionnaire  to  evaluate  re-exposure  and  drug  refusal.
ome  carers  were  interviewed  several  years  after  DPT  and
e-exposure,  and  this  might  introduce  some  recall  bias.
lthough  we  tried  to  confirm  that  patients  reporting  HSR
n  re-exposure  were  indeed  describing  HSR  symptoms,  no
dditional  allergological  workup  was  performed  to  confirm
rue  sensitisation.  It  has  been  suggested  that,  as  with  index
vent,  some  subsequent  HSR  reports  on  re-exposure  are
ot  ‘‘real’’  HSR4,24 and  this  might  have  underestimated  the
PV  in  our  study  (however,  at  an  expected  rate  in  the  two
rotocols).  The  presence  of  non-allergic  side-effects,  likely
rising  more  frequently  during  extended  DPT,  was  not  eval-
ated  in  our  study  and  this  might  influence  willingness  to
se  the  same  drug  besides  fear  of  the  HSR.  The  hypothetical
nfluences  of  the  time  intervals  between  HSR  and  DPT  and
lso  between  DPT  and  re-exposure  were  not  analysed.  How-
ver,  these  putative  effects  are  mitigated  by  the  fact  that,
nalysing  a  paediatric  population  (average  age  at  DPT  =  5.52
ears),  these  intervals  were  never  very  long.
In  conclusion,  we  did  not  find  additional  benefits  in
rolonging  DPT  both  in  terms  of  NPV  and  confidence  for
ntibiotic  use.  However  intuitive,  any  modifications  of  DPT
rotocols  should  be  adequately  compared  with  previous
tandard  practice  for  sensitivity,  specificity,  predictive  val-
es,  side-effects  and,  importantly,  patients/carers  adhesion
o  the  DPT  result.  Given  the  low  event  rate  of  HSR  on  re-
xposure  after  negative  DPT,  studies  in  large  populations  are
equired  to  determine  the  optimal  length  of  DPT.  Finally,
he  diagnostic  performance  of  DPTs  is  always  limited  by  the
ncomplete  mimicking  of  all  ‘‘real-life’’  conditions:  DPTs  are
sually  performed  in  ‘‘controlled’’  settings,  whereas  some
SR  symptoms  may  only  arise  in  the  presence  of  co-factors
ccurring  in  ‘‘real-life’’  situations,  e.g.  during  infection,
fter  physical  exercise,  or  NSAIDs  intake.  Other  issues  under
nvestigation,  such  as  the  development  of  drug  resistance
r  drug  sensitisation  during  diagnostic  procedures,  might
lso  contribute  to  determine  the  risk/benefit  of  prolonged
xposition.
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